0001317757-11-000025.txt : 20110812
0001317757-11-000025.hdr.sgml : 20110812
20110812085336
ACCESSION NUMBER: 0001317757-11-000025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110811
FILED AS OF DATE: 20110812
DATE AS OF CHANGE: 20110812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALLEN LEE F MD PhD
CENTRAL INDEX KEY: 0001408474
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10865
FILM NUMBER: 111029266
MAIL ADDRESS:
STREET 1: C/O AMAG PHARMACEUTICALS, INC.
STREET 2: 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0000792977
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042742593
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 6174983300
MAIL ADDRESS:
STREET 1: 100 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MAGNETICS INC
DATE OF NAME CHANGE: 19920703
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0304
4
2011-08-11
0
0000792977
AMAG PHARMACEUTICALS INC.
AMAG
0001408474
ALLEN LEE F MD PhD
C/O AMAG PHARMACEUTICALS, INC.
100 HAYDEN AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Medical Officer and EVP
Common Stock
2011-08-11
4
C
0
1250
A
4523
D
Common Stock
2011-08-11
4
C
0
5000
A
9523
D
Common Stock
2011-08-11
4
S
0
1959
15.04
D
7564
D
Restricted Stock Unit
2011-08-11
4
C
0
1250
A
Common Stock
1250
1250
D
Restricted Stock Unit
2011-08-11
4
C
0
5000
A
Common Stock
5000
6250
D
The shares were acquired by the reporting person as a result of the partial vesting of a restricted stock unit grant described below.
Not applicable.
The restricted stock units were scheduled to vest on August 6 and August 5, 2011, respectively. However, due to Company's black out policies and certain tax laws, both installments vested on August 11, 2011.
Each restricted stock unit represents a contingent right to receive one share of common stock.
Grant of restricted stock unit pursuant to the AMAG Pharmaceuticals, Inc. Amended and Restated 2000 Stock Plan. The grant vested in four equal, annual installments commencing August 8, 2008.
Grant of restricted stock unit pursuant to the AMAG Pharmaceuticals, Inc. Second Amended and Restated 2007 Equity Incentive Plan. This grant vests as follows: 50% on August 5, 2010, 25% on August 5, 2011 and the remaining 25% on August 5, 2012.
Joseph L. Farmer, attorney-in-fact
2011-08-12